Spots Global Cancer Trial Database for A New Track Ablation Device for Liver Biopsy: A Feasibility Study

Study Description

Brief Summary: The purpose of this study is to evaluate the effectiveness and safety of a new biopsy track ablation device for liver biopsy.

Detailed Description: Background: * Percutaneous biopsy for hepatic masses has a potential risk of bleeding and peritoneal tumor seeding. * A new device for biopsy track ablation has been invented to reduce the risk of bleeding and peritoneal tumor seeding. Method: * Routine percutaneous biopsy for hepatic masses is performed. * Immediate after obtaining tissue, biopsy needle track is ablated with a new biopsy tract ablator. * Immediate (with ultrasound) and 24 hours (with CT scan) after procedure, occurrence of complications is evaluated.

Keywords

Eligibility

Minimum Age: 20 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Contact Details

Useful links and downloads for this trial